STAT1 and neuroblastoma: Other investigators have found that major histocompatibility complex (MHC) Class I antigen presentation, a downstream sequalae of STAT1 [52], is dysregulated in high-risk neuroblastoma, which could indicate the ability for increased viral replication over time as we saw with the two high-risk PDXs in the current study [53,54].